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TITLE: Comparison of the Functional Exercise Capacity outcome between Horizontal 
and Graded Treadmill exercise training in Myocardiac Infarction patients  
Leung, S.Y., PT 
 
ABSTRAST 
 
The purpose of the study was to compare the functional exercise capacity outcome 
between Horizontal and Graded Treadmill exercise training in Myocardial Infarction 
patients. Twenty patient participants who had myocardial infarction with Percutaneous 
Coronary Intervention (PCI) were recruited in the study. They were randomly assigned 
into Horizontal Treadmill (HT) Training Group or Graded Treadmill (GT) Training 
Group. Both groups underwent the same Phase II Cardiac Rehabilitation Program (CRP) 
which consisted of 2 sessions weekly that lasted for 8 weeks, including 10-minute warm 
up, 20-minute treadmill walking training, 10-minute upper arm ergometer, 10-minute 
resistance training using cuff weight and 10-minute cool down. 6-minute Walk Test was 
used as the functional exercise capacity outcome. All subjects were tested pre- and 
post-program. HT group (n=14, Male: Female= 13:1; mean age: 65.79  8.40 years old) 
needed to walk on a horizontal-treadmill (at gradient 0%); while GT group (n=6, Male: 
Female= 4:2; mean age: 56.33 14.69 years old) needed to walk on graded-treadmill (at 
gradient 13%). Both groups walked with the speed that could achieve the training heart 
rate for 20 minutes. Non-parametric test, that was Mann-Whitney U test and Wilcoxon 
test were adopted for the between group analysis and within group analysis respectively. 
After Phase II CRP, there were no significant difference between GT group and HT 
group in 6-minute walk distance (6MWD). However, there was significant gain in 
6MWD (from 433.00  66.50m to 498.50  88.75m, p<0.001) after the program. It was 
concluded that there was no significant difference in the functional capacity outcome 
between Horizontal and Graded Treadmill exercise training in Myocardiac Infarction 
patients.  
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Chapter 1. INTRODUCTION 
 
Coronary artery disease (CAD) is a major source of mortality and morbidity in 
many developed countries (American Heart Association, 2000). In Hong Kong, it is the 
second leading cause of death (Department of Health, 2002). In this group of patients, 
angina pectoris and ischemic left ventricular dysfunction limit exercise capacity, and 
result in deteriorating physical performance (Ades, 2001). Besides, fear for physical 
discomfort such as exertional dyspnea and/ or fatigue is another reason limiting the 
physical activity (Ades, 2001). This inactivity leads to a general physical deconditioning 
and a reduced aerobic performance (Ades, 2001; and Ades and Grundvald, 1990), hence 
exercise training in Cardiac Rehabilitation Program (CRP) is vital to them. Exercise can 
improve aerobic capacity together with quality of life (QOL); and prevent risk factors as 
well as new cardiac events (Ades, 2001; and Ades and Grundvald, 1990), and hence 
decreasing the mortality and morbidity rates. 
 
CRP has traditionally been categorized as Phase I (inpatient), Phase II (up to 12 
weeks of supervised exercise, and/ or education following hospital discharge), Phase III 
(variable length program of intermittent, of no electrocardiographic [ECG] monitoring 
under supervision), and Phase IV (no ECG monitoring, limited supervision) (Franklin, 
Whaley, and Howley, 2000). It usually adopts multi-disciplinarily approach, including 
cardiac doctor, nurses, physiotherapists, occupational therapists, dietitians, clinical 
psychologist and social worker. The main part of exercise training in CRP is the aerobic 
exercise training, which involves a variety of equipment, for example, treadmill, cycle 
and arm ergometer, stair-climber, cross-trainer, and rowing machine. Among all, 
walking is the most common form of physical conditioning in most exercise-based CRP, 
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since it is the most functional mode of movement in daily life (Morris and Hardman, 
1997). 
 
Brisk walking, which was defined as ≥70% of maximal heart rate (HRmax), could 
achieve aerobic training threshold in healthy people, [(Porcari et al. (1987); and 
Spelman et al. (1993); cited in Quell et al (2002)]. Besides, it could improve health 
outcomes and aerobic capacity [Bendall, Bassey, and Pearson (1989); cited in Quell et 
al (2002)]. It had the similar results in most of the cardiac patients as well (Quell et al, 
2002). Therefore, brisk walking was not just used as in treadmill training, it was also 
highly recommended as home exercise for both healthy people (Bendall, Bassey, and 
Pearson, 1989; cited in Quell et al., 2002) and cardiac patients (Quell et al., 2002). Quell 
and his colleagues (2002) found that cardiac patients who could walk within the range 
2.2 to 4.5mph (3.52 to 7.2 kmh-1), could generally achieved a training heart rate (THR) 
(i.e. ≥70% of HRmax). However, whether brisk walking on level ground or slope was 
not stated. 
 
Walking is a good mode of training (Morris and Hardman, 1997), which is widely 
used in CRP. During walking on the treadmill, the slope and the speed are adjusted so as 
to achieve the THR. However, there is no guideline to direct how to make a good 
balance between these two factors so as to generate the most efficient training. In 
traditional exercise training, it was well-known that low-to-moderate intensity with long 
duration program showed comparable benefits to higher-intensity with shorter duration 
ones (Blumenthal et al., 1988; cited in Quell et al., 2002). Similarly, for treadmill 
walking training, whether the horizontal walking with higher speed, or graded walking 
with lower speed is more efficient to improve the functional exercise capacity, is 
uncertain. Only those studies investigated the energy cost and the gait modification at 
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graded treadmill and horizontal treadmill were found. In the study of Ardigò, Saibene, 
and Minetti (2003), they found that extra work was needed for slope walking to against 
the gravity, resulted in high metabolic cost that was generated by the muscles. They also 
found that at low gradient, the speed increased to values that was closed to or above the 
speed at which running became more economical than walking, on the contrary, at the 
slope about 13-15%, walking was more economical than running. Similar result was 
found in study of Minetti, Ardigò and Saibene (1993; cited in Ardigò, Saibene, and 
Minetti, 2003). At preferred transition speed (PTS), which was the transition between 
walking and running gait, was about 6.84-7.56km.h-1 in human (Hreijac,1993; 
Thorstensson, and Roberthson, 1987), running at PTS resulted in a significantly lower 
Rate of Perceived Exertion (RPE) but higher energy cost than walking, and more 
muscle works were resulted (Rotstein, Inbar, Berginsky, and Meckel, 2005) . 
 
Although most activities of daily living were performed at submaximal levels of 
exertion, patients with cardiac disease often presented with limited activity levels and 
exercise capacity which affected their normal daily living. In the previous studies 
(Guyatt, et al., 1985; and Lipkin, Scriven, Crake, and Poole-Wilson, 1986), assessing 
exercise capacity with walking tests was proved to be incorporated with heart disease, 
therefore a functional walking test was needed to reflect the functional exercise level for 
daily physical activities. Functional walk tests were typically administered as a means 
of evaluating functional status or capacity, mainly the ability to undertake physically 
demanding activities of daily living (Guyatt, et al., 1985); monitoring treatment 
effectiveness, and establishing prognosis(Singh, 1992). More importantly, they 
employed an activity that individuals performed on a daily basis, i.e. walking (Singh, 
1992). Likewise, walking tests were concluded to be an effective means of assessing 
everyday functional ability in clinical groups with severe illness (Steele, 1996). In a 
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qualitative systematic review (Solway, Brook, Lacasse, and Thomas, 2001), the authors 
compared a variety of walk tests, they concluded that the measurement properties of the 
6 minute walk test (6MWT) had been the most extensively researched and established. 
It was easy to administer, better tolerated, and more reflective of activities of daily 
living than the other walk tests. 6MWT was also demonstrated to be the test of choice 
when using a functional walk test for clinical or research purposes. It was one of the 
most popular and reliable clinical exercise tests for evaluating functional capacity 
(Moalla, Gauthier, Maingourd, and Ahmaidi, 2005). It was also defined as “a patient’s 
ability to undertake physically taxing activities encountered in everyday life” (Steele, 
1996). It could give an objective indication of functional capacity and exercise 
intolerance, since there was a significant correlation between 6MWD and peak oxygen 
uptake (Cahalin, Pappagianopoulos, Prevost, Wain, and Ginns, 1995; Hamilton and 
Haennel, 2000). In addition, walking capacity was a factor in the Quality of Life (QOL) 
of cardiac patients (Demers, McKelvie, Negassa, and Yusuf, 2001). 6MWT was a 
practical, simple, safe and inexpensive test, and did not require any exercise equipment 
(The American Thoracic Society, 2002). Besides, it was easy to administer, better 
tolerated, and more reflective of activities of daily living than the other walk test 
(Solway, Brooks, Lacasse, and Thomas, 2001), although it could determine peak oxygen 
uptake, diagnose the cause of dyspnea on exertion, or evaluate the causes for 
mechanisms of exercise limitation (Weisman and Zeballos, 1994; cited in The American 
Thoracic Society, 2002). Hence, in this study, 6MWT was chosen to be the outcome 
measurement for comparing the functional exercise capacity of horizontal-treadmill and 
graded-treadmill walking training in CRP. 
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 In this study, there were 2 groups of patients underwent either Graded-treadmill 
(GT) walking training or Horizontal-treadmill (HT) walking training in Phase II CRP. 
After completed the rehabilitation program, their functional exercose capacity were 
compared using 6MWT. Since the extent of increasing speed in HT group was 
anticipated to be greater than in GT group (Kuster, Sakurai, and Wood, 2002; Ardigò, 
Saibene, and Minetti 2003) for achieving the training heart rate (THR), subjects in HT 
group will be expected to have a greater 6 minute walk distance (6MWD) than those in 
the GT group. This hypothesis mainly depended on the training specificity on the HT 
and the speed dependent nature in 6MWT. Therefore, the null hypothesis was that the 
functional aerobic capacity which measured by 6MWT in HT group was lower than that 
in GT group. For the aim of this study, was to compare the functional exercise capacity 
outcome of Horizontal-Treadmill (HT) walking training with Graded-Treadmill (GT) 
walking training of myocardiac infarction patients in Phase II CRP. 
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Chapter 2. METHOD 
 
 
2.1 Subjects 
 
Thirty-two subjects who had myocardial infarction with Percutaneous Coronary 
Intervention (PCI) done and referred for CRP by physicians at Tung Wah Hospital were 
recruited (Table 1) within the period from June 2006 to January 2008. All of them 
needed to undergo a symptom-limited graded exercise testing which was not longer than 
6 months before entering the Phase II CRP. According to Quell et al. (2002), those who 
attained an average 10 metabolic equivalents (METs) or above could not reach a THR 
(i.e. ≥70% of HRmax) during brisk walking, and their (RPE) were lower. Therefore, to 
avoid the ceiling effect of the 6MWT (Bubb, Martin, and Howley, 1985), subjects with 
lower MET level, that was below 10 METs, were selected (Table 1). 
 
6MWT was used for functional exercise capacity evaluation, however there were 
factors that would influence 6MWD, such as pulmonary disease, musculoskeletal 
diseases and communication problem (Enright, et al., 2003). Therefore, the exclusion 
criteria (Table 1) includes: inability to walk, communication disorders, symptomatic 
peripheral occlusive arterial disease, pulmonary disease (chronic obstructive pulmonary 
disease, asthma, cystic fibrosis, interstitial lung disease), cerebrovascular disease, 
musculoskeletal disorders (arthritis, ankle, knee, or hips injuries, muscle wasting, etc.), 
or severe exertional arrhythmias. Besides, all subjects were advised not to have extra 
exercise training this Phase II CRP to avoid the extra training effect.  
 
All subjects read a description of the experimental design, and the testing 
procedures and potential risks were explained individually (Appendix I). If the subject 
agreed after reviewing the description, written informed consent (Appendix I) was 
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obtained with the presence of witness. Afterwards, he or she was assigned to either 
Horizontal-Treadmill (HT) training group or Graded-Treadmill (GT) training group 
randomly by drawing lots. They could withdraw from the study at any time without 
giving a reason. Any enquires were welcomed to ask the researcher. The following data 
were recorded in this study: gender, age, height, weight, Body mass Index (BMI), Body 
Fat (BF), Waist-Hip-Ratio (WHR), functional exercise capacity that was measured by 
6MWTD, and the aerobic capacity (MET) that was measured by the symptom-limited 
stress test. After completing Phase II CRP, the above measurements were repeated. The 
study was approved by the Institutional Review Board of University of Hong Kong/ 
Hospital Authority Hong Kong West Cluster (HKU/ HA HKW IRB). All procedures 
were conducted in accordance with ethical standards of the committee on human 
experimentation (Appendix H). 
 
Table 1. Inclusion and exclusion criteria for the study 
 
Inclusion criteria Exclusion criteria 
Patients who had myocardia 
infarction with Percutaneous 
Coronary Intervention (PCI) 
done 
Aerobic capacity > 10METs 
Inability to walk 
Communication disorders 
Symptomatic peripheral occlusive arterial disease 
Pulmonary disease (chronic obstructive pulmonary 
disease, asthma, cystic fibrosis, interstitial lung disease) 
Cerebrovascular disease 
Musculoskeletal disorders (arthritis, ankle, knee, or hips 
injuries, muscle wasting, etc.)  
Severe exertional arrhythmias 
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2.2 Study Design  
 
It was a true experimental study design. No control group was involved. The 
dependent variable was the mode of treadmill training in Phase II CRP, 
Horizontal-treadmill (HT) training group versus Graded-treadmill (GT), and the 
independent variable was the effect of exercise training in Phase II CRP. 
 
2.3 Procedure 
 
In Phase II CRP, it consisted of 2 sessions weekly that lasted for 8 weeks. HT 
group and GT group needed to follow the HT and GT training protocol respectively. 
Both groups underwent the same cardiac rehabilitation training program, including 
10-minute warm up, 20-minute treadmill walking training, 10-minute upper arm 
ergometer (Figure 1), 10-minute resistance training using cuff weight (Figure 1) and 
10-minute cool down.  
 
For HT training group, subjects needed to walk on a horizontal-treadmill (at 
gradient 0%) (Figure 2) with the speed that could achieve the THR (Table 2). For GT 
training group, the subjects needed to walk on graded-treadmill (at gradient 13%) 
(Figure 3), with the speed that could achieve the THR (Table 3). The THR was reached 
on the 4th minute during treadmill walking in both groups. After 20 minutes, both 
groups of patients had 1 more minute to cool down at subject’s own comfortable speed. 
All the subjects put on telemetry on the first day of exercise training for ECG (Figure 4) 
monitoring. If it was stable, heart rate monitor (Figure 5) was used instead in the next 
time and onwards. The highest heart rate during exercise, blood pressure, RPE (Table 4), 
and any sign and symptom was recorded after each mode of exercise. Other parts of the 
CRP (i.e. doctor’s consultation, physiotherapy, occupational therapy, education talks, 
and individual counseling by psychologist, social worker or dietician) were similar for 
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both groups. 
Table 2. The progression of Treadmill training in HT training group 
Minute 0 1st 2nd 3rd 4th-20th 21st 
Grading 0% 
Speed 
The speed was adjusted 
gradually to achieve the 
THR 
The speed was adjusted 
to maintain THR till 
the 20th minute 
Comfortable 
walking 
speed 
 
Table 3. The progression of Treadmill training in GT training group 
Minute 0 1st 2nd 3rd 4th-20th 21st 
Grading 13% 
Speed 
The speed was adjusted 
gradually to achieve the 
THR 
The speed was adjusted 
to maintain THR till 
the 20th minute 
Comfortable 
walking 
speed 
 
 
Table 4. Borg’s Scale for Ratings of Perceived Exertion (RPE) (Franklin, Whaley, and 
Howley, 2000) 
 
6 
7 Very, very light 
8 
9 Very light 
10 
11 Fairly light 
12 
13 Somewhat hard 
14 
15 Hard 
16 
17 Very hard 
18 
19 Very, very hard 
20 
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Figure 2. Horizontal-Treadmill (HT) 
at gradient 0% 
 
Figure 3. Graded-Treadmill (GT) 
at gradient 13% 
 
Figure 4. Telemetry for ECG monitoring 
Figure 5. Heart Rate Monitor 
 
Figure 1. Upper Arm Ergometer and 
Cuff Weight 
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2.3.1Training heart rate (THR) 
 
THR was used as an index of exercise intensity (Lake, Henderson, Briffa, 
Opershaw, and Musk, 1990). The result of symptom-limited graded exercise testing was 
a reference method for assessing the exercise capacity (Fletcher, et al., 2001). The 
resting heart rate (RHR) and the peak heart rate (MHR) obtained before and during the 
symptom-limited graded exercise test respectively, was used to calculate the heart rate 
reserve (HRR). THR will be calculated by using the MHR reserve method of Karvonen, 
as it was closely approximate the same percentage of the oxygen uptake “reserve” 
(%VO2R) (Franklin, Whaley, and Howley, 2000). 
  
 
 
 
 
 
 
 
2.4 Measurements and Apparatus 
 
2.4.1 Body weight, height and Body Mass Index (BMI) 
  
Body weight (kg) and height (m) were measured by the cardiac nurse using the 
weighing machine (Figure 6). BMI was calculated through the following equation: 
 
  
 
 
2.4.2 Body Fat 
 
The subjects’ body fat was measured by the researcher using the LANGE 
SKINFOLD CALIPER (Figure 7). It was a precision instrument specifically designed 
for the simple, accurate measurement of subcutaneous tissue. Exclusively manufactured 
by Beta Technology Incorporated, it was widely recognized by medical and physical 
 
THR= (MHR-RHR) x 40 – 85% + RHR 
(Franklin, Whaley, and Howley, 2000) 
BMI= Weight/ Height2 
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fitness professionals as a leader in the field. Its scale range was 0-60mm, and the 
accuracy was ±1mm. According to the operation manual, 4 sites were measured (Table 
5). Three measurements were taken from each site. Average of the 3 was measurement 
of that skinfold. Sum of the 4 skinfolds was transformed to the percentage of the body 
fat through the Tables which was in the operation manual. 
 
Table 5. Location of the skinfold measurement 
 
Triceps Between the tip of the olecranon process of the ulna (elbow) and the acromion process of the scapula (shoulder) 
Biceps: Midpoint of the flexed bicep muscles 
Subscapular Below tip inferior angle scapula 45
o to vertical (back- just under 
shoulder blade) 
Suprailiac Above iliac crest in mid-axillary line (approximately 2.5cm above hip bone) 
 
 
 
2.4.3 Waist-Hip-Ratio (WHR) 
 
 Waist and hip circumference (cm) were measured by the researcher using the tap 
measure (Figure 7). The body mark for waist circumference was the umbilical cord, 
while the hip circumference was the largest circumference around the hip.  
 
 
 
 
 
2.4.4 Treadmill 
 
The treadmill used for the study was TRUE, 700ZHRC (serial number: 04-717588) 
(Figure 2 and Figure 3). The gradient range was 0%- 13%. The speed range was 0-12 
mile per hour (mph), with fine adjustment 0.1mph for each press. A safety hooked was 
attached to patients for security.  
WHR= Waist circumference/ Hip circumference 
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2.4.5 6-Minute Walk Test (6MWT) 
 
Before the subjects entered the first day of exercise training, their initial functional 
exercise capacity was assessed by using 6MWT, which was only done by the researcher. 
After completing Phase II CRP, it was evaluated. 
 
a. Required equipment (Modified from The American Thoracic Society, 2002) 
 
1. 10 meters long, flat, straight, and enclosed corridor with a hard surface. There is a 
sharp marking at 0 meter, 5 meter, and 10 meter (Figure 8 and Figure 9).  
2. Countdown timer (Figure 10) 
3. Lap counter (Figure 10) 
4. Oximeter for Blood Oxygen Concentration (SaO2) Monitoring (Figure 10) 
5. A chair that can be easily moved along the walking course (Figure 11) 
6. A source of oxygen (Figure 12) 
7. Sphygmomanometer (Figure 13) 
8. Telephone (Figure 14) 
Figure 6. Weighing Machine for 
body weight and height 
Tape Measure 
Figure 7. The LANGE SKINFOLD 
CALIPER for body fat measurement 
and the Tape Measure for WHR 
Lange Skinfold Caliper 
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9. Automated electronic defibrillator (Figure 15) 
10. Telemetry (Figure 4) 
 
Figure 8. A 10m long corridor 
marking 0m 
Figure 9. A 10m long corridor 
marking 5m and 10m 
Figure 10. Countdown Timer, Lap 
Counter, and Oximeter 
Figure 13. 
Sphygmomanometer  
0m 
10m 
5m 
Countdown Timer 
Oximeter 
Counter 
Figure 11. Chair 
Figure 12. Source of 
oxygen 
Figure 14. Telephone 
Figure 15. Automated 
electronic defibrillator 
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b. Patient preparation (The American Thoracic Society, 2002) 
 
1. Comfortable clothing  
2. Appropriate shoes for walking. 
3. Usual walking aids during the test 
4. Usual medical regimen 
5. No vigorously exercised within 2 hours before the test 
 
c. Procedures (Modified from The American Thoracic Society, 2002) 
 
1. The patient should sit at rest in a chair, located near the starting position, for at least 
10 minutes before the test starts. During this time, measure pulse rate, blood 
pressure and oxygen saturation (SaO2).  
2. Set the lap counter to zero and the timer to 6 minutes. 
3. Instruct the patient as follows: 
 “The objective of this test is to walk as far as possible for 6 minute, but not run or 
jog. You will walk back and forth in this corridor with marking at each end. If you 
have any reasons that let you cannot continue the test, for example, chest pain, 
intolerable dyspnea, leg cramps, staggering, diaphoresis, please let me know. You 
are permitted to slow down, to stop, and to rest as necessary, but resume walking as 
soon as you are able. I will inform you the rest of the time for every two minutes. 
You can start whenever you are ready.” 
4. Start the time as soon as the patient starts to walk 
5. Do not walk with patient or talk to anyone during the walk 
6. Click the lap counter when the patient reaches to each end of the marking, i.e. 0 and 
10m. 
7. Use an even tone of voice to inform the patient the time left and to give the standard 
phrases of encouragement for every two minute. 
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 When the timer shows 4 minutes remaining, tell the patient the following: “Keep up 
the good work, you have 4 minutes to go.”  
 When the timer shows 2 minutes remaining, tell the patient the following, “You are 
doing well, you have only 2 minutes left.” 
 If the patient stops walking during the test and needs a rest, say this: “You can take a 
rest if you like, then continue walking whenever you feel able.” If the patient stops 
before the 6 minutes are up and refuses to continue, record the distance walked and 
the time stopped, and the reason for stopping prematurely. 
When the timer rings, say “Stop! Go to have the vital sign measurement” 
8. Record the distance walked to the nearest 10 m. 
9. Measure the blood pressure, pulse rate and SaO2; record any sign and symptoms; note 
the reason to stop before 6 minutes if any; and ask the patient for the RPE (Table 4). 
10. Congratulate the patient on good effort 
 
Standard phrases for encouragement must be used during the test, since 
encouragement significantly increases the distance walked. (Guyatt, Pugsley, Sullivan, 
Thompson, Berman, Jones, Fallen, and Talyer, 1984; cited in American Thoracic 
Society, 2002) 
 
6MWT could be stopped where there was chest pain, intolerable dyspnea, leg 
cramps, staggering, diaphoresis, or pale of ashen appearance. The patient was requested 
to sit or lie supine as appropriate depending on the severity and the risk of syncope. 
Blood pressure, pulse rate, and SaO2 were measured. A physician evaluation was needed 
if indicated. (The American Thoracic Society, 2002) 
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2.4.6 Stress Test 
 
Graded exercise test could be very stressful for elderly, deconditoined individuals, 
and patients with heart disease. Symptom-limited graded exercise testing was similar to 
maximal testing, but with more cautious termination criteria. It was one of the 
diagnostic tests for coronary artery disease, and can help identify a patient’s ischemic 
threshold. The test was conducted by a nurse and a doctor with the subject walking on a 
motor-driven treadmill, where after a warm-up period, the speed and/ or grade was 
progressively increased that was followed the Modified Bruce Protocol (Table 6). 
Modified Bruce Protocol was chosen rather than the Bruce Protocol because it was less 
stressful to the sedentary and elderly. It was peak or symptom-limited exercise treadmill 
testing. It was useful for establishing safe levels of exercise performance and to 
determine an appropriate exercise prescription for a subject. Subjects were encouraged 
to exercise to volitional fatigue or until they had limiting symptoms (for example, 
fatigue, dizziness, leg pain, chest discomfort and shortness of breath). Heart rate and 
function were monitored continuously throughout the test by a 12-lead 
electrocardiograph, and blood pressure was taken every 3 minutes. All at once, during 
each exercise stage and recovery stage, blood pressure, heart rate, ischemic ST-segment 
depression (defined as ≥1mm of horizontal or downsloping ST-segment depression 
80ms after the J point), cardiac rhythm, and exercise workload were recorded. During 
the treadmill testing, tight gripping of the handrails was not allowed, since it could 
decrease the actual energy expenditure and increase performance time, resulting in an 
overestimation of aerobic capacity. [Ragg et al. (1980); cited in Quell et al (2002)]. The 
test was terminated by the physician at the time of onset of fatigue, breathlessness, chest 
pain, or other symptoms. Aerobic fitness of each patient would be estimated from the 
treadmill testing, which was based on the treadmill speed, grade, and test duration 
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(minutes) by using American College of Sports Medicine prediction equations (Kenny, 
Humphrey, and Bryant, 1995). It was expressed as metabolic equivalents (METS) [1 
MET= 3.5mLO2/kg/min]. The result of the stress test was needed to set the training 
intensity and to assess the training effects during a cardiac rehabilitation program. 
 
Table 6. Modified Bruce Protocol 
 
Stage Speed (mph) Gradient (%) 
Duration 
(minute) 
1 1.7 0 3 
2 1.7 5 3 
3 1.7 10 3 
4 2.5 12 3 
5 3.4 14 3 
6 4.2 16 3 
7 5.0 18 3 
8 5.5 20 3 
9 6.0 22 3 
10 6.5 24 3 
11 7.0 26 3 
12 7.5 28 3 
 
 
2.4.7 Safety Issues 
 
Emergency trolley (Figure 16) was available, including oxygen, sublingual 
nitroglycerine, aspirin, and albuterol. A telephone was in place to enable a call for help. 
Nurses who had certified in cardiopulmonary resuscitation with a minimum of basic 
Life Support by an American health Association were present. 
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2.4.8 Statistical Analyses 
 
 Data was analyzed by using SPSS 11.0 statistical software. All results were 
expressed as mean ±SD (Appendix A – G). Descriptive statistics of the baseline 
clinical characteristics of the subjects were carried out. Theoretically, normality of the 
distribution of the data should be evaluated by the Kolmogorov-Smirnov test. If the data 
were normally distributed, parametric independent t-test and paired t-test should be used 
for the comparison between groups and within groups respectively. If the data were not 
normally distributed, the non-parametric test would be used instead, that was 
Mann-Whitney U test for the between group analysis, and Wilcoxon test for the within 
group analysis. The between group factor was the mode of treadmill training in Phase II 
CRP, Horizontal-treadmill (HT) training group versus Graded-treadmill (GT), and the 
within group factor was pre and post test comparison from exercise training in Phase II 
CRP. The statistical significant value was set as p-value < 0.05. 
  
 
 
Figure 16. Emergency Trolley 
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 Because of the small subject size (GT group, n=6; HT group, n=14), normality test 
would not be used. Even though the data were evenly distributed, parametric test was 
not suitable, as the power of the analysis was not strong enough. Hence, non-parametric 
test was chosen as a substitute, that was Mann-Whitney U test for the between group 
analysis, and Wilcoxon test for the within group analysis. 
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Chapter 3. RESULTS 
  
 
Thirty-two subjects were recruited within the period from June 2006 to January 
2008. However, only 20 subjects could complete the Phase II CRP. All subjects could 
achieve the THR zone during training and no adverse sign or symptoms were noticed. 4 
males and 2 females (n= 6) were completed in the Graded-Treadmill (GT) walking 
group; and 13 males and 1 female (n= 14) were completed in the horizontal-Treadmill 
(HT) walking group. The dropout rate was 37.5%. The reasons for withdrawing 
included turning down to join the Phase II CRP, needing to work, poor compliance 
which less than 13 sessions completed, withholding training because of atrial flutter, 
unable to tolerate 20min graded treadmill training and, still in the waiting list for Phase 
II CRP (Table 7). 
 
Table 7. Reasons for dropout the study 
 
Reasons for dropout Number of subjects 
Refuse to join the Phase II exercise training 2 
Need to work 1 
Poor compliance which less than 13 sessions completed 3 
Need to withhold training because of atrial flutter  1 
Cannot tolerate 20min graded treadmill training 1 
Still in the waiting list for Phase II exercise training 4 
 
 
3.1 Baseline clinical characteristics 
 
 A total of 20 participants completed the study. Four males and 2 females (n= 6) 
were in the GT group; and 13 males and 1 female (n= 14) were in the HT. 
 
 The baseline clinical characteristics of the two groups were compared (Table 8 & 
Appendix A - C). All the data were expressed in mean  standard deviation (SD). 
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Among the subjects, the mean age of GT group and HT group was 56.33  14.69 and 
65.79  8.40 respectively; the mean height was 1.63  0.11 and 1.63  0.06 meters 
respectively; the mean weight was 63.57  10.23 and 64.10  9.24kg respectively; the 
mean BMI was 23.82  1.92 and 23.99  2.53 respectively; the mean body fat was 
32.58  6.65% and 30.98  6.08% respectively; the mean WHR was 0.97  0.066 and 
0.96  0.05 respectively; the mean initial 6MWD was 446.67  87.33m and 427.14  
58.37m respectively; and the mean aerobic capacity from stress test was 6.58  3.13 
METs and 5.98  2.63 METs respectively. Because of the small subject numbers, 
non-parametric Mann-Whitney U test was used for between group analyses. Since the 
p-value were all > 0.05, at the baseline clinical characteristics, GT group and HT group 
were identical, that meant there was no significant difference in age, height, weight, 
BMI, body fat, WHR, initial 6MWD and initial aerobic capacity .  
 
Table 8. Baseline subjects clinical characteristics before Phase II CRP 
. 
 GT group 
(n=6) 
HT group 
(n=14) 
p-value 
Male: Female 4:2 13:1 --------- 
Age (years) 56.33  14.69 65.79  8.40 0.172 (NS) 
Height (m) 1.63  0.11 1.63  0.06 0.648 (NS) 
Weight (kg) 63.57 10.23 64.10  9.24 0.869 (NS) 
BMI 23.82  1.92 23.99  2.53 0.934 (NS) 
BF (%) 32.58  6.65 30.98  6.08 0.536 (NS) 
WHR 0.97  0.066 0.96  0.05 0.772 (NS) 
6MWD (m) 446.67  87.33 427.14  58.37 0.649 (NS) 
Aerobic Capacity 
(METs) 
6.58  3.13 5.98  2.63 0.508 (NS) 
Values were presented as the mean  SD. BMI, Body Mass Index; BF, Body fat; WHR, Waist Hip Ratio; 
6MWD, 6 Minute Walk Distance. NS, No significant difference  
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3.2 After Phase II CRP 
 
 After Phase II CRP, the clinical characteristics were compared again between 2 
groups (Table 9 & Appendix A,B & D). The mean weight of GT group and HT group 
was 63.28  8.38kg and 64.86  8.37kg respectively; the mean BMI was 23.8  2.11 
and 24.26  2.13 respectively; the mean body fat was 32.88  7.38% and 31.68  6.14% 
respectively; the mean WHR was 0.96  0.05 and 0.96  0.04 respectively; and the 
mean 6MWD was 526.67  143.06m and 486.43  55.83m respectively; and the final 
mean aerobic capacity was 9.47  2.89 METs and 8.83  2.39 METs respectively. 
Non-parametric Mann-Whitney U test was used again between group analyses. Since 
the p-value were all > 0.05, therefore, there were no significant difference between GT 
group and HT group after Phase II CRP in weight, BMI, body fat, WHR, 6MWD and 
aerobic capacity.  
 
Table 9. Comparison of the clinical characteristics between GT group and HT group 
after Phase II CRP. 
 
 GT group 
(n=6) 
HT group 
(n=14) 
p-value 
Weight (kg) 63.28  8.38 64.86  8.37 0.934 (NS) 
BMI 23.8  2.11 24.26  2.13 0.592 (NS) 
BF (%) 32.88  7.38 31.68  6.14 0.773 (NS) 
WHR 0.96  0.05 0.96  0.04 0.934 (NS) 
6MWD (m) 526.67  143.06 486.43  55.83 0.869 (NS) 
Aerobic Capacity 
(METs) 
9.47  2.89 8.83  2.39 0.901 (NS) 
Values were presented as the mean  SD. BMI, Body Mass Index; BF, Body fat; WHR, Waist Hip Ratio; 
6MWD, 6 Minute Walk Distance. NS, No significant difference  
  
  
 Since there was no significant difference between GT group and HT group after 
Phase II CRP in weight, BMI, body fat, WHR, 6MWD and aerobic capacity, the net 
value of these data (i.e. the difference before and after Phase II CRP) were compared 
again (Table 10, Appendix A, B & E). Non-parametric Mann-Whitney U test was used 
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for between group analyses. Although there were changes after Phase II CRP, the 
changes between 2 groups were not significant (p> 0.05).  
 
 
 
Table 10. Comparison of the net change of clinical characteristics between GT group 
and HT group before and after Phase II CRP. 
 
 GT group 
(n=6) 
HT group 
(n=14) 
p-value 
Weight (kg) -0.28  3.34 +0.76  2.78 0.458(NS) 
BMI -0.02  1.13 +0.27  1.08 0.563 (NS) 
BF (%) +0.03  0.96 +0.70  3.47 0.457 (NS) 
WHR -0.01  0.04 -0.00  0.03 0.617(NS) 
6MWD (m) +80  63.56 +59.29  37.92 0.507 (NS) 
Aerobic Capacity 
(METs) 
+2.88  1.78 +2.85  1.69 0.620 (NS) 
Values were presented as the mean  SD. “+” value, gain after Phase II CRP; “-“ value, loss after Phase II 
CRP; BMI, Body Mass Index; BF, Body fat; WHR, Waist Hip Ratio; 6MWD, 6 Minute Walk Distance. 
NS, No significant difference 
 
 
3.3 Training effect of Phase II CRP 
  
Concerning the training effect of Phase II CRP, weight, BMI, body fat, WHR, 
6MWD, the maximum heart rate in 6MWT and aerobic capacity were compared before 
and after training (Table 11, Appendix A, B, &F). Since there was no significant 
difference between 2 groups for the above categories after training, GT group and HT 
group were combined together for analyses so as to increase the statistical power (Table 
8). Because of the small subject number, non-parametric Wilcoxon Test was used for 
within group analysis. It showed that there was no significant difference after Phase II 
CRP training in weight, BMI, body fat, WHR and the maximum heart rate in 6MWT  
(p>0.05). However, there was significant difference in 6MWD and aerobic capacity 
after training (p<0.05). It showed that there was significant gain in 6MWD and aerobic 
capacity after Phase II CRP training. 
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Table 11. Comparison of the Training effect of the Phase II CRP with the combination 
of GT group and HT group 
 
 Before Phase II CRP 
GT group + HT 
group 
(n=20) 
After Phase II CRP 
GT group + HT 
group 
(n=20) 
p-value 
Weight (kg) 63.94  9.27 64.39  8.18 0.587(NS) 
BMI 23.94  2.32 24.12  2.08 0.494 (NS) 
BF (%) 31.46  6.12 32.04  6.36 0.287(NS) 
WHR 0.96  0.05 0.96  0.04 0.628(NS) 
HR in 6MWT 109.3  19.55 105.55  18.23 0.341 (NS) 
6MWD (m) 433.00  66.50 498.50  88.75 0.000 (S) 
Aerobic Capacity 
(METS) 
6.16  2.72 9.02  2.49 0.000(S) 
Values were presented as the mean  SD. BMI, Body Mass Index; BF, Body fat; WHR, Waist Hip Ratio; 
max. HR in 6MWT, maximum heart rate in 6 minute walk test; 6MWD, 6 Minute Walk Distance. NS, No 
significant difference; S, significant difference 
 
 
 
 
 
3.4 Correlation between 6MWT and Stress test 
  
Concerning the correlation between 6MWT and the stress test, the result of 6MWD 
and the aerobic capacity after Phase II CRP training were used. The Pearson correlation 
was 0.747, showing there was moderate correlation between 6MWD and aerobic 
capacity (Table 12, Figure 17 & Appendix G). 
 
 
Table 12. Correlation between 6MWT and Stress test 
Correlations
1 .747**
. .000
20 20
.747** 1
.000 .
20 20
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
SIXMWT2
STRESS2
SIXMWT2 STRESS2
Correlation is significant at the 0.01 level (2-tailed).**. 
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Figure 17. Scattered chart showing the correlation of 6MWT and Stress test 
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Chapter 4. DISCUSSION 
 
4.1 Running on the Horizontal-Treadmill or Walking on the 
Graded-Treadmill 
 
The result of the study demonstrated that there was no significant difference in the 
functional exercise capacity outcome by different modes of Treadmill training, that was 
Horizontal-Treadmill (HT) walking training or Graded-Treadmill (GT) walking training, 
for myocardiac infarction patients in Phase II Cardiac Rehabilitation Program (CRP). 
Besides, there were also no significant changes in weight, BMI, body fat, and waist-hip 
ratio after training. However, after the Phase II CRP, the improvement in functional 
exercise capacity and the aerobic capacity were statistically significant. Furthermore, it 
showed that 6MWT was well correlated with stress test. 
 
This implied that during the Phase II CRP, the mode of treadmill training was not 
the main concern. If THR was achieved, both the functional exercise capacity and the 
aerobic capacity could be improved. However, what the differences were between these 
2 modes of training, and what factors should be affecting the decision whether 
increasing the speed or the gradient, were uncertain. There should be some differences 
in physiological adaptation between HT and GT training.  
 
The HT group had a gradient 0%, while the GT group had a gradient 13%. If 
walking at HT, speed had to be increased so as to achieve the THR, however, to some 
extend, patients needed to change from walking to jogging with variable transition 
points, resulted in a variety of mechanical efficiencies with varying oxygen costs. In HT 
group, the mean speed range was 3.280 0.904 kmh-1 – 5.770 1.122 kmh-1 (Table13). 
By observation, some patients had difficulties in walking in a faster speed or even 
needed to jog. In the GT group, the mean speed range was 2.460 0.836 – 4.833 1.796 
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kmh-1 (Table 13). Within this speed range, no jogging or running was observed.  Hence, 
there was no transition point when walking on the treadmill at gradient 13%, variations 
on VO2 dependent on biomechanical factors were avoided. 
 
Table 13. The speed in HT group and GT group (Appendix B) 
 
 Speed (kmh-1) 
 Phase II CRP Minimum Maximum Mean SD 
HT group At the 1
st session 2.240 4.800 3.280 0.904 
Last session 3.520 7.800 5.770 1.122 
GT group At the 1
st session 1.400 3.840 2.460 0.836 
Last session 2.600 7.200 4.833 1.796 
 
 
To achieve the THR, subjects in both groups needed to speed up, however, the 
extend of speed increasing was greater in the HT group than GT group. Therefore, to a 
certain speed, subjects in HT group might need to jog or run. These two distinct 
movement patterns, the walking and the running gaits, characterized human terrestrial 
locomotion. The transition between the walking and running gait was characterized by a 
discrete and relatively abrupt change, which was dependent on the movement speed. In 
healthy human, the preferred transition speed (PTS) which was the preferred speed 
changed from walking to running, typically occurred at a speed of about 
6.84-7.56km.h-1 (Hreijac,1993; Thorstensson, and Roberthson, 1987). Prilutsky and 
Gregor (2001) found that the preferred walk-run transition might be triggered by the 
increased sense of effort caused by the exaggerated activation of muscles associated 
with the higher joint moment demanded to move the swing leg during fast walking. 
Other than that, the influence of the human capacity for intentional gait modification 
and the importance of the physiologic and metabolic demands of the differed gaits 
might also influence the PTS (Hanna, Abernethy, Neal, and Burgess-Limerick, 2000). In 
the study of Rotstein, Inbar, Berginsky, and Meckel (2005), they found that PTS was 
7.23 0.25km.h-1 for non-runners. Moreover, running at the PTS resulted in a 
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significantly lower RPE but higher energy cost than walking at the PTS. However, the 
subjects in the HT group chose to jog even at a lower speed (3.280 0.904 kmh-1 – 
5.770 1.122 kmh-1) (Table13). Applied this adaptation to this study, subjects in the GT 
group walked within the range 2.460 0.836 – 4.833 1.796 kmh-1, there were no extra 
unnecessary energy cost was utilized for gait transition, thus the majority of the energy 
used would be for the cardiovascular training, hence would be the better training effect 
on cardiovascular system. On the contrary, the range of the mean speed of HT group 
was 3.280 0.904 kmh-1 – 5.770 1.122 kmh-1, which was faster than the GT group. 
Although the speed was lower than the common PTS, subjects needed to jog or run, and 
hence higher energy would be resulted for the gait transition. During running, the 
energy cost of locomotion was virtually independent of speed over a relatively wide 
range of velocities, and had a constant value of approximately 1 kcal.kg-1.km-1, or an 
oxygen consumption rate of approximately 200mlO2.kg-1.km-1 (Kram and Taylor, 1990). 
Even at a steep gradient at PTS, oxygen consumption was the same if one run supported 
by the handrail or one walked without holding on at the treadmill 3.4mph (5.44kmh-1), 
at gradient 14% (Zohman, Young, and Kattus, 1983). Therefore, if the subjects run 
below or in their PTS, higher energy cost would be resulted despite the energy 
expenditure was not optimized (Rotstein, Inbar, Berginsky, and Meckel, 2005). 
Consequently, the training effect on the cardiovascular aspect would be lowered 
theoretically. Furthermore, Rotstein, Inbar, Berginsky, and Meckel (2005) found that 
RPE for walking at or faster than the PTS were significantly higher than for running at 
the same speeds. Such patterns of change in RPE with velocity may indicate that 
perceived exertion, being sensitive, among other factors, to proprioceptive input at low 
intensity exercise, may be a significant determinant of the PTS.  
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In another similar study of Ardigò, Saibene, and Minetti (2003), they found that the 
metabolic cost (energy per unit of distance) of walking on level ground at a speed of 
about 1.3 ms-1 (4.68kmh-1) was 2Jkg-1m-1. If the walking speed exceeded 2.5 ms-1 
(9kmh-1), running would become more economical, because the metabolic cost was 4 
Jkg-1m-1 for all speed. According to this Ardigò, Saibene, and Minetti (2003)’s result, 
subjects in HT group did not jog or run in a energy economical way. They also found 
that when walking and running on a level surface, raising or lowering; and accelerating 
or decelerating the body’s centre of mass cyclically were needed during each stride. 
This was related to the positive or negative work that constituted the mechanical 
external work. The amount of positive work was equal and opposite to the amount of 
negative work on level ground, resulting in apparently no work was being done. 
However, muscles consumed metabolic energy for both positive and negative work, 
where the positive work was five times higher than the negative one, it resulted in high 
metabolic cost. 
 
For slope walking, extra work was needed to against the gravity. Therefore, for the 
same metabolic power, the progression speed was expected to decrease at steep slope. It 
was factual in this study (Table 13). At steep slope, the chosen speed was low and 
typical for a walking gait. At low gradient, the speed increased to values that was closed 
to or above the speed at which running became more economical than walking, on the 
contrary, at the slope about 13-15%, walking was more economical than running. 
Minetti, Ardigò and Saibene (1993; cited in Ardigò, Saibene, and Minetti, 2003) found 
that walking and running were known to require at gradients steeper than 15%, only the 
positive external work corresponding to the increase in potential energy at each stride. 
As a result, for an economical point of view, walking training in a graded-treadmill 
rather than jogging/ running on the horizontal treadmill was preferred. 
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The transition from a level to an inclined surface presented a number of challenges 
to locomotor control system. Swing limb trajectories had to be modified to ensure safe 
toe clearance and foot placement as the elevation and orientation of the support surface 
changes. Similarly, the geometric configuration of body segments and postural support 
had to be altered as the direction at which the ground reaction forces acted upon the foot 
changes with the support surface orientation. A significant decrease in walking speed 
had been found when walking up a step ramp of greater than 9o which was characterized 
by a decrease in cadence, while little difference in waking speed had been noted 
between level ground and lower grade ramps (Kawamura, Tokuhiro, and Takechi, 1991). 
Similar result was found in another study (Minetti, Ardigò and Saibene, 1993; cited in 
Ardigò, Saibene, and Minetti, 2003). This phenomenon was observed in this study 
(Table 13). Changes in muscle activity had also been linked to the slope of the waling 
surface. Tokuhiro, Nagashima, and Takechi (1985) studied the phasic activity of the 
lower extremity muscles during upslope walking, including tibialis anterior, 
gastrocnemius, rectus femoris, semitendinosus, and gluteus maximus. They found that 
muscle activation patterns during walking changed with ramps having a slope greater 
than 6o. It indicated that the muscles stabilized the knee and ankle joint much more in 
slope walking than in level walking. It appeared that the typical level walking pattern 
might require little modification for small grade ramps; however, steeper grades seemed 
to require changes in the motor patterns to provide the additional joint stability, 
propulsion and limb guidance to accommodate the changing support surface (Leroux, 
Fung, and Barbear, 2002). This adaptation was in response to the increased postural and 
propulsion demands associated with the change in orientation of the support surface. 
Hence more muscle work was needed at the inclined surface that was greater than 6o. 
Although only walking was required on a graded-treadmill, more muscle work on lower 
extremity was needed. It implied that graded-treadmill training was good for muscle 
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intensification as well.  
 
Even though the mode of treadmill training (GT or HT) had no significant 
influence on the gain in functional exercise capacity in this study, the importance of 
treadmill training in cardiac rehabilitation was assured. In Goodman, McKenzie, Nath, 
Schamberger, Taunton, and Ammann’s study (1995), they concluded that walking or 
jogging training produced greater left ventricular function improvements versus circuit 
training after 6 months in coronary artery disease patients, possibly due to differences in 
the exercised muscle mass. During walking or jogging training, the large leg skeletal 
muscle mass was trained and did so continuously, however, during circuit training, 
smaller muscle masses was trained and the exercise was interrupted during switching 
between modes. Although walking or jogging training was mainly training the large leg 
muscles, it had evidence that there was a transfer of fitness to the arms as well. Hence, 
longer walking training was worth in Phase II CRP or even for exercise prescription in 
the community. 
 
According to the previous studies above, it seemed that running was not a good 
form of exercise. Besides, it could result in injuries to the lower extremities. Gudas 
(1980) concluded that the most common injury of running was knee problems, others 
were toe and forefoot injuries, inferior heel and arch pain, skin splints, ankle pain, calf 
and Achilles tendon pain, groin and hip pain, and stress fractures. Therefore, running 
was not recommended in cardiac rehabilitation and exercise description in the 
community. 
  
The effect of training specificity was another point to be considered. If the mode of 
movement used in exercise prescription was similar to that in the outcome assessment, 
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the more significant would be the improvement. (Nieuwland, Berkhuysen, landsman Lie, 
and Rispens, 1998). Training effects specific to the mode of movement might be the 
result of improved (motor) skills, strength and metabolism of the working muscles. 
Learning phenomenon was important. In Fernhall and Kohrt’s study (1990), they found 
that during submaximal exercise, training specificity was significant in treadmill for the 
trained runners rather than the trained bikers. This was most likely due to the effect of 
specificity of training on local muscle adaptation, recruitment and blood flow 
(Verstappen, Huppertz, and Snoeclex, 1983; and Withers, Sherman, Miller, and Costill, 
1981). It was attributed to be the function of local peripheral actors, rather than central 
cardiovascular factors. For the same principle, since 6MWD was speed dependent, 
greater 6MWD was expected in the HT group as the extend of speed increasing was 
greater in HT group rather than in the GT group. However, there was no significant 
difference between 2 groups. This might due to many reasons, such as the small subject 
number, short training period, and subjects’ motivation to walk. Further research will be 
needed in the future. 
 
By observation, subjects in HT group had difficulties in walking at a faster speed 
or changing the mechanic from walking to jogging for achieving the THR zone; on 
contrary, in GT group, subjects were comparably easier to keep walking at gradient 13%. 
Besides, base on the previous studies, it seemed that walking was better than running. It 
was spent less unnecessary extra metabolic cost, more energy economical, and had less 
adverse impact on the lower extremities. Walking on a steeper gradient could have the 
muscle strengthening effect as well. According to James, Susan, Dorothy, Ruth, and 
Rowland (1996), they found that joint impairment and quadriceps strength contributed 
significantly the threshold in walking velocity among older people. It further supported 
that running should be avoided for the elderly to avoid the joint injuries, and slope 
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walking should be recommended for quadriceps strengthening as well.  
 
 
4.2 6MWT 
6MWT was completed by all the subjects without premature end or breaks. No 
symptoms or clinical complications occurred during the test. The maximum heart rate 
during 6MWT before and after Phase II CRP were 109.30  19.55 and 105.55  19.23 
bpm (beat per minute). Since the maximum heart rate between these 2 occasions had no 
significant difference (p>0.05) (Table 11), the improvement in the 6MWD was due to 
the training effect of the Phase II CRP. After Phase II CRP, the improvement of 6MWD 
in GT group was from 466.67  87.33m to 526.67  143.06m, the gain was 60m 
(12.86%); whereas in HT group was from 427.14  58.37m to 486.43  55.83m, the 
gain was 59.29m (13.88 %), which was compatible with the 15% improvement in 
6MWD in subjects with different heart diseases in the previous study (Bittner, 
Sanderson, Breland, Adam, and Schuman, 2000). Regarding to Wright, Khan, Gossage 
and Saltissi (2001), even though their period of cardiac rehabilitation programme was 
shorter than this study (45 minutes of aerobic and weight resistant exercise, twice 
weekly sessions for a period of six weeks), the functional capacity could also be 
increased significantly (from mean 314.7 76.2 to 377.3  78.6m, p< 0.001; the gain 
was 62.6m, 19.89%). On the other hand, a noticeable change in functional status by 
6MWT was 54m (Redelmeier et al., 1997), and it was about 60m in this study. 
Therefore, all subjects in this study had improvement in the functional exercise capacity 
clinically and statically (p<0.05, Table 11). That implied Phase II CRP could help the 
patients to improve the functional exercise capacity, regardless of the mode of Treadmill 
training. However, if 6MWT was used for assessing the women over 75 years of age, 
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one more factor should be kept in mind that the muscular strength of the leg, that would 
determine walking speed and step length (Ringsberg, Gerdhem, Johansson, Obrant, 
1999), would affect the 6MWD as well. Furthermore, as previously proved that joint 
impairment and quadriceps strength contribute significantly to the threshold in walking 
velocity among older people (James, Susan, Dorothy, Ruth, and Rowland, 1996). In 
addition, the distance walked decreased with older age, with men walking farther than 
women (Hamilton and Haennel, 2000).  
 
Although 6MWT was a submaximal exercise test that mimicked daily activities 
and was generally well tolerated by patients (Eng, Chu, Dawson, Kim, and Hepburn, 
2002), in some circumstances, it could have a level of cardiorespiratory demand closed 
to that of the symptom-limited graded exercise test at ventilatory threshold in the elderly 
patients with coronary artery disease (CAD) with LVEF above 35%. It indicated that 
6MWT was not systematically a submaximal effort, it could be a maximal effort for 
some elderly patients with CAD. Therefore, it was a valid alternative for conventional 
laboratory testing in elderly patients with coronary artery disease with LVEF above 35% 
(Gayda, Temfemo, Choquet, Ahmaїdi, 2004). 
 
4.3 Aerobic Capacity 
Concerning the stress test, the improvement in GT group was form 6.58  3.13 
METs to 9.47  2.89METs, the gain was 2.89METs (43.92%); whereas in HT group was 
from 5.98  2.63 METs to 8.83  2.39 METs, the gain was 2.85METs (47.66%). Some 
studies only had 9-11% improvement with the similar training intensity through 12 
weeks training period (Paillard, Lafon, Costes-Salon, Rivière, and Dupui, 2004; and 
Braith, Pollock, Lowenthal, Graves, and Limacher, 1994). However, HT or GT training 
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had no significant difference in aerobic capacity improvement (Table 10). It implied that 
if the THR was achieved, the aerobic capacity could be improved significantly (p<0.05, 
Table 11). 
 
Concerning the correlation of 6MWT and the stress test, it was again proved. In 
this study, it showed that 6MWT was moderately correlated with stress test (r=0.747, 
p<0.001)), which was compatible with the other study (Hamilton and Haennel, 2000; 
and Cahalin, Pappagianopoulos, Prevost, Wain, and Ginns, 1995). 
  
 43
Chapter 5. CLINICAL IMPLICATION 
 
The result of this study could give an idea for the physiotherapists in determining 
the exercise prescription in the mode of treadmill training, whether horizontal or graded 
Treadmill would be used in Phase II CRP. Moreover, it was essential for the home 
exercise prescription and the advice for the patients in the rehabilitation program 
onwards. For Phase III and IV exercise prescription, which were community-based, 
although the exercise intensity might be below those commonly prescribed for 
cardiorespiratory conditioning (that is ≤70% HRmax), health benefits may be achieved, 
for example, bone density, glucose tolerance, coronary risk factors and cardiovascular 
related mortality (Blair, et al., 1989). Therefore, the training regimen which was 
associated with a reduced cardiovascular and orthopedic risk, and hence improving the 
exercise adherence, was an important factor in home exercise prescription. 
 
Walking was highly recommended in cardiac rehabilitation (Morris and Hardman, 
1997; and Franklin, 2000) as it was one of the normal activities of life. It could reflect 
the capacity to undertake daily activities (Enright and Sherrill, 1998). A mere walking 
program could improve cardiac function in previously sedentary or relatively inactive 
adults (Woolf-May, Bird, and Owen, 1997) and modify the body composition in 
overweight women (Kinkleman, and Nieman, 1993). In heart failure patients, the 
changes in skeletal muscle metabolism and function due to detraining could be 
reversible with regular exercise (Sullivan, Green, Cobb, 1991; and Sullivan, 
Higginbotham, and Cobb, 1988). As a general policy, a gradual progression was 
indicated from slow, to regular pace and on to 30 minutes or more of brisk (i.e. 6.4kmh-1) 
walking on most days. These levels should achieve the major gains of activity and 
health-related fitness without adverse effects. The average middle-aged person should 
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be able to walk 1.6km comfortably on the level at 6.4kmh-1 and on a slope of 1 in 20 at 
4.8 kmh-1. The physiological threshold or “comfort” represents 70% of maximum heart 
rate (Morris and Hardman, 1997). However, losses in calf and quadriceps strength 
together with orthopedic or musculoskeletal limitations were age-related, might limit 
how fast patients could walk, and hence hampered their ability to achieve and adequate 
training intensity. [Bendall, Bassey, and Pearson, 1989; cited in Quell et al., 2002]. A 
recent review of an inpatient cardiac exercise program revealed that an average,” 
self-selected:” comfortable walking speed was 1.76 0.48kmh-1 (Franklin, Pamatmat, 
Johnson, Scherf, Mitchell, and Rubenfire, 1982). In Phase II CRP or onwards, the speed 
for walking exercise should be increased. In a study (Paillard, Lafon, Costes-Salon, 
Rivière, and Dupui, 2004), the authors found that a brisk walking program at average 
78% of the heart rate reserve, 45-60minutes for each session, 5 sessions per week for 12 
weeks, could increase the VO2max (9%) and loss of fat mass in ageing healthy active 
men. In another study (Braith, Pollock, Lowenthal, Graves, and Limacher, 1994), the 
authors found that with training intensity at 80-85% heart rate reserve for 3 months, 
11% increase in VO2max was resulted. It was compatible with the ACSM’s 
recommendation (Franklin, Whaley, and Howley, 2000), exercise intensities for 
outpatient cardiac rehabilitation participants are generally prescribed in the range 60 to 
80% of aerobic capacity, which approximates 70 to 85% HRmax. 
 
The relationship between maximal speed walked on the stress test (at 10% grade) 
and the heart rate resulting from walking at the same treadmill speed on the flat was 
examined (Zohman, Young, and Kattus, 1983). Zohn et al. (1983) advised the patients 
with healed MI to walk on the level ground at the maximal speed attained during 
treadmill walking at 10% grade would put the patient in the target heart rate zone for 
exercise training. They found that 8 of the 13 patients had heart rates within their target 
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range when exercise was prescribed by this method, however, the other 5 patients were 
below their target rate. These results suggested that this walking protocol was useful 
both for providing activity guidelines upon hospital discharge after infarction, and for 
exercise programming later on. Brisk walking on the other hand could result in 
significant in training effect on oxygen consumption, blood pressure, and heart rate, as 
well as favorable changes in body composition in 20 weeks (Pollock, et al., 1971). It 
also offered the advantages of fewer orthopedic problems than jogging. 
 
In conclusion, walking should take an important role in cardiac rehabilitation and 
the home exercise in the community. Brisk walking was preferred than running; and 
walking on a slope was preferred than walking on level ground at approximates 70 to 
85% HRmax. 
. 
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Chapter 6. LIMITATIONS 
 
6.1 Subjects Recruitment 
  
Although the recruitment period was long, the number of appropriate subjects was 
small, since the majority had other medical and/or physical problems, for example, 
pulmonary disease and stroke history, which fell into the exclusion criteria (Table 1). 
Besides, the recruitment was stopped for 10 weeks (from April to July 2007) due to the 
author’s maternal leave, and no alternative colleague could substitute due to the limited 
human resource. Many ignored suitable subjects were anticipated. Even if 32 suitable 
subjects were successfully recruited, the phase II exercise training was overdosed by 
another study which was carried out by our cardiologists and medical students. Their 
study period was started from November 2007 to July 2008 which including 80 subjects 
in the society, at the same time, they used the facilities and occluded the training 
sessions which should be for the patients who entered into Phase II CRP, hence resulted 
in lengthening the subjects’ normal waiting time. Unfortunately, some of them could not 
wait and hence dropped out, and some were still in the pipeline (Table 7). The adverse 
effects for the present patients had been discussed with the corresponding cardiologists, 
but no agreement could be made. In addition, the Phase II CRP needed 16 sessions to be 
completed, it further lengthened the study period; and some subjects’ data were 
abandoned because of the poor compliance. Due to the difficulties in recruitment, 
control group was inescapably discarded. The above rationales were believed to be the 
utmost obstacle of the study. 
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6.2 6MWT 
 
Although there were many advantages of using 6MWT as a functional exercise 
capacity measurement, it had limitations. Firstly, it had the ceiling effect. There was 
clearly a biomechanical ceiling as to how fast a given individual could walk, and since 
somatic oxygen consumption was related to walking velocity, (Bubb, Martin, and 
Howley, 1985) more highly fit individuals were limited in their ability to increase 
exercise intensity sufficiently to reach a training threshold. Besides, the length of the 
walking course was suggested to be 30m in length (The American Thoracic Society, 
2002). Unavoidably, the most suitable place for 6MWT in Tung Wah Hospital has only 
10m long, whereas, a shorter corridor required patients to take more time to reverse 
directions, and hence, might reduce the 6MWD (The American Thoracic Society, 2002). 
Other factors were listed in Table 14 (Enright, et al., 2003), however, most of them had 
been excluded in the study. Distance walked by elderly with CAD might not solely 
affected by their aerobic metabolism (Gayda, Temfemo, Choquet, Ahmaїdi, 2004), but 
also influenced by their walking technique, metabolism intervention and muscle 
weakness (Ades, 2001). 
 
  To obtain a reliable 6MWD, 3 trials should be done to establish a consistency 
(Solway, Brook, Lacasse, and Thomas, 2001; and Guyatt, et al., 1985), since 6MWD 
could improve by 60m (Guyatt et al., 1955) or 6% (Hamilton and Haennel, 2000) or 
even 17% (American Thoracic Society, 2002) over 3 walks. Performance (without an 
intervention) usually reached a plateau after two tests done within a week (Butland, 
Pang, Gross, Woodcock and Geddes, 1982). The training effect might be due to 
improved coordination, finding optimal stride length, and overcoming anxiety 
(American Thoracic Society, 2002). Therefore, 6MWT should include an initial learning 
session, since a number of patients might be inhibited by the fear of developing 
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symptoms during the test. According to American Thoracic Society (2002), at least 1 
hour rest was preferred for the second test. However, in this study, only 1 trial was taken, 
as 3 trials was time-consuming and would make our subjects exhausted, which was a 
difficulty in a real clinical situation. 
  
 
Table 14. Factors that affect 6MWD (Enright, et al., 2003) 
 
Factors associated with shorter 6MWD Factors associated with longer 6MWD 
Shorter height (shorter leg) Taller height (longer legs) 
Old age Male gender 
Higher body weight High motivation 
Female gender Patient has previously performed the test 
Impaired cognition Medication for a disabling disease taken just before the test 
Shorter walking corridor (more turns) Oxygen supplementation 
Chronic obstructive pulmonary disease, 
asthma, cystic fibrosis, interstitial lung 
disease 
 
Angina, myocardial infarction, 
congestive heart failure, stroke, transient 
ischemic attack, peripheral vascular 
disease, ankle-arm index 
Arthritis, ankle, knee, or hip injuries, 
muscle wasting 
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6.3 THR 
 
The training heart rate zone was mainly determined by the result of the stress test. 
However, the reliability of the stress test was queried since it was symptom-limited, the 
test would be stopped although the limiting factor might not due to the cardiac problems, 
for example, fatigue and fear. Besides, the Modified Bruce protocol required changes in 
both speed and grade between work loads, it was sometimes difficult for patients to 
accommodate to the large work increments. At times in deconditioned patients, the 
peripheral musculature may fatigue before the central circulation could be adequately 
challenged. Therefore, the exercise capacity might be under-estimated and hence, 
patients might be under-trained. Besides, the exercise capacity was not measured by gas 
exchange techniques, this might cause error in determining the THR.  
 
Chapter 7. CONCLUSION 
 
In conclusion, that there was no significant difference in the functional capacity 
outcome, in terms of 6-minute Walk Distance, between Horizontal and Graded 
Treadmill exercise training in Myocardial Infarction patients after Phase II Cardiac 
Rehabilitation Program. But both modes created a training effect that improved function 
walking costume by 15% and a reduction in heart rate relation to walking speed by 18%. 
Therefore both forms GT and HT ban be used effectively within a Cardiac 
Rehabilitation Programme.  
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Appendix A 
Raw Data in SPSS 
 
Abbreviations 
 
Group  1= Graded-treadmill (GT) walking group; 2= 
Horizontal-treadmill (HT) walking group 
Session Total sessions of Phase II CRP that the subject attended. 
Full CRP was 16 sessions 
Gender 1= Male; 2= Female 
Age Age of the subject 
Height Height (m) 
Weight 1 Weight (kg) before Phase II CRP 
Weight 2 Weight (kg) after Phase II CRP 
BMI 1 Body Mass Index before Phase II CRP 
BMI 2 Body Mass Index after Phase II CRP 
BF 1  Body Fat before Phase II CRP 
BF 2 Body Fat before Phase II CRP 
WHR 1 Waist-Hip Ratio before Phase II CRP 
WHR 2 Waist-Hip Ratio before Phase II CRP 
6MWD 1 6-minute walk distance before Phase II CRP 
6MWD 2 6-minute walk distance after Phase II CRP 
MET 1 Metabolic equivalents before Phase II CRP 
MET 2 Metabolic equivalents before Phase II CRP 
6MWdiff Difference of 6MWD1 and 6MWD2 
minT Minimum Treadmill speed  
maxT Maximum Treadmill speed 
Wdiff Difference of Weight 1 and Weight 2 
BMIdiff Difference of BMI 1 and BMI 2 
BFdiff Difference of BF 1 and BF 2 
WHRdiff Difference of WHR 1 and WHR 2 
6diff Difference of 6MWD 1 and 6MWD 2 
METdiff Difference of MET 1 and MWT 2 
6HR1pre Resting heart rate before 6MWD 1 
6HR1pos Maximum heart rate during 6MWD 1 
6HR2pre Resting heart rate before 6MWD 2 
6HR2pos Maximum heart rate during 6MWD 2 
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Group Sessions Gender Age Height Weight1 Weight2 BMI1 BMI2 BF1 BF2 WHR1 WHR2 6MWD1 6MWD2 
1 16 1 43 1.8 74 69.4 22.8 21.4 23 23 0.92 0.89 560 720 
1 14 2 73 1.53 48.7 49.8 20.8 21.3 37.7 38.7 1 1 330 390 
1 15 1 45 1.58 57.7 59 23.2 23.6 29.3 29.3 0.88 0.95 530 660 
1 16 1 63 1.71 75.5 71.5 25.8 24.5 29.2 27.9 1.07 1.04 430 450 
1 16 2 72 1.53 60 60.5 25.6 25.8 41.2 42.6 0.98 0.93 380 380 
1 16 1 42 1.63 65.5 69.5 24.7 26.2 35.1 35.8 0.96 0.96 450 560 
2 16 1 65 1.61 54.2 56 20.9 21.6 24.7 26.5 1 0.99 450 500 
2 16 1 73 1.67 62.2 65.4 22.4 23.6 26.5 30.4 0.91 0.93 410 440 
2 16 1 55 1.66 57.2 59.3 20.8 21.5 20.8 22.9 0.89 0.95 410 470 
2 16 2 73 1.52 56 59.9 24.2 25.9 41.2 43.9 0.96 1.01 390 410 
2 15 1 54 1.64 68.6 67 25.5 24.9 31.6 32.7 0.95 0.95 490 520 
2 14 1 65 1.64 64 67.7 23.8 25.12 30.4 37.4 0.96 0.98 440 470 
2 16 1 58 1.71 64.4 67.5 22 23.1 34.8 34.8 0.97 0.97 530 610 
2 15 1 57 1.64 60.7 63.7 22.6 23.7 22.9 24.7 0.91 0.9 450 480 
2 15 1 59 1.64 74.4 72.7 27.7 27 32.7 31.6 0.93 0.9 500 500 
2 16 1 65 1.66 73.1 75.4 26.5 27.4 32.7 36.6 0.95 0.95 390 460 
2 16 1 77 1.49 54.8 51.3 24.7 23.1 31.6 30.4 1.02 0.98 350 450 
2 15 1 68 1.73 85.5 81.2 28.6 27.1 41.1 39 1.06 1.04 310 410 
2 16 1 72 1.6 53.6 53.6 20.9 20.9 27.9 24.7 0.94 0.93 420 530 
2 16 1 80 1.65 68.7 67.3 25.2 24.7 34.8 27.9 1.03 0.99 440 560 
               
MET1 MET2 6MWdiff minT maxT Wdiff BMIdiff BFdiff WHRdiff 6diff METdiff 6HR1pre 6HR1pos 6HR2pre 6HR2pos
10 13 160 2.8 7.2 -4.6 -1.4 0 -0.03 160 3 85 151 84 142 
2 6 60 1.4 2.6 1.1 0.5 1 0 60 4 60 75 57 90 
7 11.5 130 3.84 5.76 1.3 0.4 0 0.07 130 4.5 60 107 80 135 
3.8 7.8 20 2.24 4.8 -4 -1.3 -1.3 -0.03 20 4 102 117 71 90 
7.3 7 0 1.92 2.88 0.5 0.2 1.4 -0.05 0 -0.3 74 134 72 97 
9.4 11.5 110 2.56 5.76 4 1.5 0.7 0 110 2.1 72 95 84 114 
7 9 50 2.4 6 1.8 0.7 1.8 -0.01 50 2 75 112 75 101 
3 8 30 2.4 5.4 3.2 1.2 3.9 0.02 30 5 70 80 73 94 
7 7 60 3.6 6.4 2.1 0.7 2.1 0.06 60 0 83 120 75 113 
4 7 20 2.4 5.9 3.9 1.7 2.7 0.05 20 3 84 126 80 105 
9 9.7 30 3.84 6.08 -1.6 -0.6 1.1 0 30 0.7 62 130 68 108 
6 8.1 30 4.8 6.08 3.7 1.32 7 0.02 30 2.1 80 98 72 94 
10 13.4 80 4.6 7.8 3.1 1.1 0 0 80 3.4 71 92 67 130 
10 13.5 30 3.6 7 3 1.1 1.8 -0.01 30 3.5 52 82 51 83 
2.3 8.9 0 3.2 6.08 -1.7 -0.7 -1.1 -0.03 0 6.6 59 99 57 96 
6.6 8.6 70 3.84 4.8 2.3 0.9 3.9 0 70 2 81 110 84 106 
4.7 8.7 100 2.24 3.52 -3.5 -1.6 -1.2 -0.04 100 4 59 122 77 103 
1.9 4.6 100 2.24 3.84 -4.3 -1.5 -2.1 -0.02 100 2.7 86 100 50 72 
6.9 10.1 110 2.6 5.8 0 0 -3.2 -0.01 110 3.2 87 111 93 104 
5.3 7 120 4.16 6.08 -1.4 -0.5 -6.9 -0.04 120 1.7 84 125 72 134 
Appendix B 
SPSS output of Descriptive statistics of subjects clinical characteristics  
Descriptive Statistics 
HT group 
 N Minimum Maximum Mean 
Std. 
Deviation 
SESSIONS 14 14.00 16.00 15.5714 .64621 
GENDER 14 1.00 2.00 1.0714 .26726 
AGE 14 54.00 80.00 65.7857 8.39577 
HEIGHT 14 1.49 1.73 1.6325 .06393 
WEIGHT1 14 53.60 85.50 64.1000 9.23913 
WEIGHT2 14 51.30 81.20 64.8571 8.37319 
BMI1 14 20.80 28.60 23.9857 2.53191 
BMI2 14 20.90 27.40 24.2586 2.12835 
BF1 14 20.80 41.20 30.9786 6.08266 
BF2 14 22.90 43.90 31.6786 6.13655 
WHR1 14 .89 1.06 .9629 .04921 
WHR2 14 .90 1.04 .9621 .04003 
SIXMWT1 14 310.00 530.00 427.1429 58.36603 
SIXMWT2 14 410.00 610.00 486.4286 55.83039 
STRESST1 14 1.90 10.00 5.9786 2.62889 
STRESS2 14 4.60 13.50 8.8286 2.39115 
SMWDIFF 14 .00 120.00 59.2857 37.91981 
TREDMIN 14 2.24 4.80 3.2800 .90360 
TREDMAX 14 3.52 7.80 5.7700 1.12150 
WTDIFF 14 -4.30 3.90 .7571 2.78477 
BMIDIFF 14 -1.60 1.70 .2729 1.07953 
BFDIFF 14 -6.90 7.00 .7000 3.47364 
WHRDIFF 14 -.04 .06 -.0007 .02999 
SIXMDIFF 14 .00 120.00 59.2857 37.91981 
STRESSDI 14 .00 6.60 2.8500 1.68648 
GT group 
 N Minimum Maximum Mean 
Std. 
Deviation 
SESSIONS 6 14.00 16.00 15.5000 .83666 
GENDER 6 1.00 2.00 1.3333 .51640 
AGE 6 42.00 73.00 56.3333 14.69240 
HEIGHT 6 1.53 1.80 1.6300 .10752 
WEIGHT1 6 48.70 75.50 63.5667 10.22891 
WEIGHT2 6 49.80 71.50 63.2833 8.38413 
BMI1 6 20.80 25.80 23.8167 1.91877 
BMI2 6 21.30 26.20 23.8000 2.11187 
BF1 6 23.00 41.20 32.5833 6.64573 
BF2 6 23.00 42.60 32.8833 7.37710 
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WHR1 6 .88 1.07 .9683 .06585 
WHR2 6 .89 1.04 .9617 .05269 
SIXMWT1 6 330.00 560.00 446.6667 87.33079 
SIXMWT2 6 380.00 720.00 526.6667 143.06176 
STRESST1 6 2.00 10.00 6.5833 3.13204 
STRESS2 6 6.00 13.00 9.4667 2.88560 
SMWDIFF 6 .00 160.00 80.0000 63.56099 
TREDMIN 6 1.40 3.84 2.4600 .83589 
TREDMAX 6 2.60 7.20 4.8333 1.79571 
WTDIFF 6 -4.60 4.00 -.2833 3.34151 
BMIDIFF 6 -1.40 1.50 -.0167 1.12679 
BFDIFF 6 -1.30 1.40 .3000 .95917 
WHRDIFF 6 -.05 .07 -.0067 .04227 
SIXMDIFF 6 .00 160.00 80.0000 63.56099 
STRESSDI 6 -.30 4.50 2.8833 1.78148 
 
HT group and GT group 
Descriptive Statistics
20 42.00 80.00 62.9500 11.17080
20 1.49 1.80 1.6317 .07642
20 48.70 85.50 63.9400 9.27375
20 49.80 81.20 64.3850 8.18633
20 20.80 28.60 23.9350 2.31546
20 20.90 27.40 24.1210 2.07835
20 20.80 41.20 31.4600 6.12427
20 22.90 43.90 32.0400 6.35671
20 .88 1.07 .9645 .05296
20 .89 1.04 .9620 .04275
20 310.00 560.00 433.0000 66.49891
20 380.00 720.00 498.5000 88.75009
20 1.90 10.00 6.1600 2.71863
20 4.60 13.50 9.0200 2.48863
20 .00 160.00 65.5000 46.28004
20 1.40 4.80 3.0340 .94401
20 2.60 7.80 5.4890 1.37953
20
AGE
HEIGHT
WEIGHT1
WEIGHT2
BMI1
BMI2
BF1
BF2
WHR1
WHR2
SIXMWT1
SIXMWT2
STRESST1
STRESS2
SMWDIFF
TREDMIN
TREDMAX
Valid N (listwise)
N Minimum Maximum Mean Std. Deviation
 
 
 Descriptive Statistics 
 
  N Mean 
Std. 
Deviation Minimum Maximum 
SMW1BMIN 20 74.3000 12.73660 52.00 102.00 
SMW1BMAX 20 109.3000 19.54509 75.00 151.00 
SMW2BMIN 20 72.1000 11.38281 50.00 93.00 
SMW2BMAX 20 105.5500 18.23090 72.00 142.00 
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Appendix C 
SPSS output of Comparison of the baseline clinical characteristics of HT group 
and GT group before Phase II CRP 
 
 
NPar Tests 
Mann-Whitney Test 
Ranks
6 10.83 65.00
14 10.36 145.00
20
6 10.67 64.00
14 10.43 146.00
20
6 11.75 70.50
14 9.96 139.50
20
6 11.08 66.50
14 10.25 143.50
20
6 11.42 68.50
14 10.11 141.50
20
6 11.83 71.00
14 9.93 139.00
20
GROUPING
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
WEIGHT1
BMI1
BF1
WHR1
SIXMWT1
STRESST1
N Mean Rank Sum of Ranks
 
Test Statisticsb
40.000 41.000 34.500 38.500 36.500 34.000
145.000 146.000 139.500 143.500 141.500 139.000
-.165 -.083 -.620 -.289 -.455 -.662
.869 .934 .536 .772 .649 .508
.904a .968a .547a .779a .659a .547a
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)
WEIGHT1 BMI1 BF1 WHR1 SIXMWT1 STRESST1
Not corrected for ties.a. 
Grouping Variable: GROUPINGb.   
Ranks 
  GROUPING N 
Mean 
Rank 
Sum of 
Ranks 
AGE grade 
treadmill 6 7.75 46.50
horizontal 
treadmill 14 11.68 163.50
Total 20  
HEIGHT grade 
treadmill 6 9.58 57.50
horizontal 
treadmill 14 10.89 152.50
Total 20  
Test Statistics(b) 
  AGE HEIGHT 
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Mann-Whitney U 25.500 36.500
Wilcoxon W 46.500 57.500
Z -1.366 -.456
Asymp. Sig. (2-tailed) .172 .648
Exact Sig. [2*(1-tailed 
Sig.)] .179(a) .659(a)
a  Not corrected for ties. 
b  Grouping Variable: GROUPING 
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Appendix D 
SPSS output of Comparison of the clinical characteristics of HT group and GT 
group after Phase II CRP 
 
 
NPar Tests 
Mann-Whitney Test 
Ranks
6 10.33 62.00
14 10.57 148.00
20
6 9.42 56.50
14 10.96 153.50
20
6 11.08 66.50
14 10.25 143.50
20
6 10.33 62.00
14 10.57 148.00
20
6 10.83 65.00
14 10.36 145.00
20
6 10.75 64.50
14 10.39 145.50
20
GROUPING
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
WEIGHT2
BMI2
BF2
WHR2
SIXMWT2
STRESS2
N Mean Rank Sum of Ranks
 
Test Statisticsb
41.000 35.500 38.500 41.000 40.000 40.500
62.000 56.500 143.500 62.000 145.000 145.500
-.082 -.537 -.289 -.083 -.165 -.124
.934 .592 .773 .934 .869 .901
.968a .602a .779a .968a .904a .904a
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)
WEIGHT2 BMI2 BF2 WHR2 SIXMWT2 STRESS2
Not corrected for ties.a. 
Grouping Variable: GROUPINGb.  
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Appendix E 
SPSS output of Comparison of the net value of clinical characteristics between GT 
group and HT group before and after Phase II CRP. 
 
 
NPar Tests 
Mann-Whitney Test 
Ranks
6 9.00 54.00
14 11.14 156.00
20
6 9.33 56.00
14 11.00 154.00
20
6 9.00 54.00
14 11.14 156.00
20
6 9.50 57.00
14 10.93 153.00
20
6 11.83 71.00
14 9.93 139.00
20
6 11.50 69.00
14 10.07 141.00
20
GROUPING
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
grade treadmill
horizontal treadmil
Total
WTDIFF
BMIDIFF
BFDIFF
WHRDIFF
SIXMDIFF
STRESSDI
N Mean Rank Sum of Ranks
 
Test Statisticsb
33.000 35.000 33.000 36.000 34.000 36.000
54.000 56.000 54.000 57.000 139.000 141.000
-.742 -.578 -.744 -.501 -.664 -.496
.458 .563 .457 .617 .507 .620
.494a .602a .494a .659a .547a .659a
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)
WTDIFF BMIDIFF BFDIFF WHRDIFF SIXMDIFF STRESSDI
Not corrected for ties.a. 
Grouping Variable: GROUPINGb.  
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Appendix F 
SPSS output of Comparison of the Training effect of the Phase II CRP with the 
combination of GT group and HT group 
 
 
NPar Tests 
Wilcoxon Signed Ranks Test 
Ranks
7a 11.64 81.50
12b 9.04 108.50
1c
20
7d 11.14 78.00
12e 9.33 112.00
1f
20
6g 9.00 54.00
11h 9.00 99.00
3i
20
10j 6.85 68.50
5k 10.30 51.50
5l
20
0m .00 .00
18n 9.50 171.00
2o
20
1p 1.00 1.00
18q 10.50 189.00
1r
20
Negative Ranks
Positive Ranks
Ties
Total
Negative Ranks
Positive Ranks
Ties
Total
Negative Ranks
Positive Ranks
Ties
Total
Negative Ranks
Positive Ranks
Ties
Total
Negative Ranks
Positive Ranks
Ties
Total
Negative Ranks
Positive Ranks
Ties
Total
WEIGHT2 - WEIGHT1
BMI2 - BMI1
BF2 - BF1
WHR2 - WHR1
SIXMWT2 - SIXMWT1
STRESS2 - STRESST1
N Mean Rank Sum of Ranks
WEIGHT2 < WEIGHT1a. 
WEIGHT2 > WEIGHT1b. 
WEIGHT2 = WEIGHT1c. 
BMI2 < BMI1d. 
BMI2 > BMI1e. 
BMI2 = BMI1f. 
BF2 < BF1g. 
BF2 > BF1h. 
BF2 = BF1i. 
WHR2 < WHR1j. 
WHR2 > WHR1k. 
WHR2 = WHR1l. 
SIXMWT2 < SIXMWT1m. 
SIXMWT2 > SIXMWT1n. 
SIXMWT2 = SIXMWT1o. 
STRESS2 < STRESST1p. 
STRESS2 > STRESST1q. 
STRESS2 = STRESST1r.  
Test Statisticsc
-.543a -.685a -1.066a -.484b -3.730a -3.785a
.587 .494 .287 .628 .000 .000
Z
Asymp. Sig. (2-tailed)
WEIGHT2 -WEIGHT1 BMI2 - BMI1 BF2 - BF1 WHR2 - WHR1 SIXMWT2 -SIXMWT1 STRESS2 -STRESST1
Based on negative ranks.a. 
Based on positive ranks.b. 
Wilcoxon Signed Ranks Testc.  
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 Ranks 
 
    N 
Mean 
Rank 
Sum of 
Ranks 
SMW2BMIN - 
SMW1BMIN 
Negative Ranks 12(a) 9.13 109.50 
Positive Ranks 7(b) 11.50 80.50 
Ties 1(c)   
Total 20   
SMW2BMAX - 
SMW1BMAX 
Negative Ranks 13(d) 10.04 130.50 
Positive Ranks 7(e) 11.36 79.50 
Ties 0(f)   
Total 20   
a  SMW2BMIN < SMW1BMIN 
b  SMW2BMIN > SMW1BMIN 
c  SMW2BMIN = SMW1BMIN 
d  SMW2BMAX < SMW1BMAX 
e  SMW2BMAX > SMW1BMAX 
f  SMW2BMAX = SMW1BMAX 
 
 
 Test Statistics(b) 
 
  
SMW2BMIN - 
SMW1BMIN 
SMW2BMAX - 
SMW1BMAX 
Z -.584(a) -.952(a)
Asymp. Sig. 
(2-tailed) .559 .341
a  Based on positive ranks. 
b  Wilcoxon Signed Ranks Test 
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Appendix G 
SPSS output of the Correlation of 6MWT and Stress Test 
 
 
Correlations 
 
Correlations
1 .747**
. .000
20 20
.747** 1
.000 .
20 20
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
SIXMWT2
STRESS2
SIXMWT2 STRESS2
Correlation is significant at the 0.01 level (2-tailed).**.  
Graph 
STRESS2
141210864
SIX
MW
T2
800
700
600
500
400
300
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Appendix H 
Ethics approval forms 
 
 69
Appendix I 
Research Information Sheet & Consent Form 
 
Research Information Sheet 
 
Research title: 
“Compare the functional exercise capacity outcome of 
Horizontal-Treadmill walking training with Graded-Treadmill walking 
training of myocardiac infarction patients in Phase II Cardiac 
Rehabilitation Program”.  
Research information: 
You are being invited to take part in a research study. Please take time 
to read the following information carefully. Please feel free to ask me if 
there is anything that is not clear or if you would like to seek more 
information. Please take time to decide whether or not you wish to take 
part. 
The objective of this study is to investigate whether different treadmill 
gradients will affect the functional exercise capacity in myocardiac 
infarction patients. This study is conducted as we want to provide an 
effective training protocol to maximize the training outcome of cardiac 
patients in rehabilitation.  
This study is a MSc project conducted by Ms. Leung Shun Yan under 
the supervision of Dr Stephen Fallows, Research Co-ordinator of Centre for 
Exercise & Nutrition Science in University College Chester. This study will 
start in November, 2006 and will end at April, 2007. 
Procedure of study 
In this study, there will be 30 subjects recruited from Cardiac 
Rehabilitation Center in Tung Wah Hospital while they are going to 
participate in Phase II Cardiac Rehabilitation Program (CRP). The Phase II 
CRP consists of 2 sessions weekly that lasts for 8 weeks. Each session 
involves 10 minutes warm up, 30 minutes aerobic training, 10 minutes 
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resistance training, and 10 minutes cool down. 
Your initial and pre-discharged functional exercise capacity will be 
assessed by using 6-minute Walk Test (6MWT). You will walk continuously 
for 6 minutes, at the fastest pace you feel you can maintain for the duration 
of the test on a 10-meter long corridor. The distance that you walk, the 
maximum heart rate, blood pressure and rate of perceived exertion (RPE) 
will be measured. 
You will be assigned to either Horizontal-Treadmill (HT) training 
group or Graded-Treadmill (GT) training group randomly by drawing lots 
with a fifty percents chance in each group. Both groups will undergo the 
same cardiac rehabilitation training program, including 10 minutes warm 
up, 20-minute treadmill walking training, 10-minute upper arm ergometer, 
10 minutes resistance training, and 10 minutes cool down. 
If you are randomized to the HT training group, you will only walk on 
a horizontal-treadmill with the speed that can achieve the training heart rate 
(THR) (Table 1). If you are randomized to the GT training group, you will 
walk on graded-treadmill, at maximum 13%, with the speed that can 
achieve the THR (Table 2). The THR will be reached on the 4th minute 
during treadmill walking in both groups. After 20 minutes, you will have 1 
more minute to cool down at your own comfortable speed. Additional parts 
of the CRP (i.e. doctor’s consultation, physiotherapy, occupational therapy, 
education talks, and individual counseling by psychologist, social worker 
or dietician) will be similar for both groups. 
On the first day of exercise training, you will be put on telemetry for 
ECG monitoring. If it is stable, heart rate monitor will be used for heart rate 
monitoring instead in the next time and onwards. The maximum heart rate 
during exercise, blood pressure, RPE, and any sign and symptom will be 
recorded after each mode of exercise. 
 After completing 8 weeks Phase II training, your functional exercise 
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capacity will be reassessed. 
 
Table 1. The progression of Treadmill training in HT training group 
Minute 0 1st 2nd 3rd 4th-20th 21st 
Grading 0% 
Speed 
The speed will be 
adjusted gradually to 
achieve the THR 
The speed will be 
adjusted to maintain 
THR till the 20th 
minute 
Comfortable 
walking 
speed 
 
Table 2. The progression of Treadmill training in GT training group 
Minute 0 1st 2nd 3rd 4th-20th 21st 
Grading 13% 
Speed 
The speed will be 
adjusted gradually to 
achieve the THR 
The speed will be 
adjusted to maintain 
THR till the 20th 
minute 
Comfortable 
walking 
speed 
 
The risk of this study is minimal. However, you may feel exhausted 
after 6MWT in the initial and pre-discharged assessments. Moreover, you 
may have muscle soreness and/or fatigue after the aerobic and resistance 
exercise training. Normally, you may have transient increased blood 
pressure and heart rate during and after the exercise, but they will be closely 
monitored. The discomfort can be prevented by doing adequate warm-up 
and cool-down exercises and take enough rest between each session. If you 
have any discomfort, you can tell the researcher immediately and a rest 
period will be allowed. In any adverse condition, the medical officer 
in-charge of the Cardiac Rehabilitation Center of Tung Wah Hospital will 
provide professional management.  
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All information which is collected about you during the course of the 
study will be kept strictly confidential. The information will be only served 
for research purpose. You will be assigned with numerical codes which will 
be involved in recording, data analysis and presentations without disclosure 
of your identities. The data may be checked by people from regulatory 
authorities to ensure that the study is carried out correctly. 
The participation is on voluntary basis. It is up to you to decide whether 
or not to take part. If you decide to take part, you will be asked to sign a 
consent form. You are free to withdraw from the study at any time without 
giving a reason. This will not affect the standard of care you receive, if any. 
A copy of this information sheet and a signed consent form will be given to 
you. 
You are welcome to ask for clarifications of your concerns or queries 
regarding to this study at any time. The researcher, Ms Leung Shun Yan can 
be reached at 25898293. 
Thank you for your participation in this study. 
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Consent Form 
Study Number: 
Subject Identification Number: 
 
Title of project: “Compare the functional exercise capacity outcome of 
Horizontal-Treadmill walking training with Graded-Treadmill walking training of 
myocardiac infarction patients in Phase II Cardiac Rehabilitation Program”. 
Research Supervisor: Dr Stephen Fallows, Research Co-ordinator of Centre for 
Exercise & Nutrition Science in University College Chester. 
 
Researcher: Ms Leung Shun Yan  
Physiotherapist II in Tung Wah Hospital 
 
I, ________________ (name of subject), hereby consent to participate in, as a subject, in 
the above research, 
 
1. I confirm that I have read and understood the information sheet dated ___/___/___ 
for the above study and have had the opportunity to ask questions, and these have 
been answered to my satisfaction. 
2. I realize that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. 
3. I realize that the results of this experiment may be published, but that my 
information will be kept confidential. 
4. I understand that any of the results and medical notes of this experiment may be 
looked at by University College Chester and Tung Wah Hospital where it is relevant 
to my taking part in research. I give permission for these individuals to have access 
to my records. 
 
Subject name: _________________   Signature: ___________________ 
 
Witness: ______________________   Signature: ___________________ 
 
Date: ________________________ 
Copies to: 
 Subject 
 Researcher’s File 
 Hospital File 
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 研究資料表 
研究標題:  
第二階段冠心病康復運動訓練：比較步行器的水平步行訓練及斜度步行
訓練，對冠心病康復者在運動機能之影響。 
研究資料: 
現誠邀閣下參予是項研究。請細心閱讀以下資料，如有疑問，歡迎
查詢，本人樂意為你解答有關問題。敬請閣下認真考慮是否參與是項研
究。 
是項研究目的在於研究冠心病患者在復康運動治療中，步行器的斜
度對他們的運動機能之影響, 對於日後在運動治療方面, 提供更有效的
處方來提高訓練的效果。這是一個由梁舜欣小姐負責的碩士課程研究項
目，並由 Centre for Exercise & Nutrition Science of University College 
Chester, Dr Stephen Fallows 監督。研究將於二○ ○ 六年十一月開始，並
將於二○ ○ 七年四月尾結束。 
在是項研究中，將會有三十位冠心病康復者參與，全部均準備參予
東華醫院心臟康復中心的第二階段訓練。在運動訓練之前，我們會利用
六分鐘步行測試來量度你的運動機能，閣下需要在一條長十米的走廊連
續步行六分鐘，並盡量以最快的步速完成。閣下的步行距離，心跳，血
壓和自我評估辛苦感覺將會被量度。完成八個星期的運動訓練後,此測
試會重覆。 
在第二階段中，運動訓練為每星期兩節，共持續八個星期，每節包
括十分鐘熱身運動，三十分鐘帶氧運動 (二十分鐘步行運動及十分鐘手
肌力計運動)，十分鐘肌肉耐力訓練，及十分鐘冷卻運動。在第一天的運
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動訓練，你需要帶上心電圖鑑察器來觀察心臟在運動時的情况。若情况
穩定，在及後的運動訓練將轉為心跳鑑察器。運動時最高心跳、血壓、
辛苦程度、及症狀和病徵均會在每次運動後紀錄。 
因我們想研究那種是最好治療病人的方法，我們需要分組比較。當
閣下符合是項研究的入選資格，我們將會以抽籤形式隨機編排到兩組中
的一組，以作研究。 
 
若閣下被編入「水平步行訓練」組，便需按照以下指引運動： 
分鐘 0 1 2 3 4-20 21 
斜度 0% 
速度 速度會逐漸調節至達到運動心率 
速度會相應調節而使運動心
率維持至第二十分鐘 
舒適的步
行速度 
 
若閣下被編入「斜度步行訓練」組，便需按照以下指引運動： 
分鐘 0 1 2 3 4-20 21 
斜度 13% 
速度 速度會逐漸調節至達到運動心率 速度會相應調節而使運動心率維持至第二十分鐘 
舒適的步行
速度 
除了以上的運動形式分別外，其他心臟康復的計劃都會大至相約，
包括醫生會診；物理治療；職業治療；教育課堂；及心理學家、營養師、
社工的個別輔導。 
如果閣下在檢查或運動的過程中感到疲累或不適, 你要立刻通知研究
員, 給予適當的休息及檢查。作為一個自願參與者, 閣下有權隨時退出是
項研究。 如您的不適持續，我們將會安排您的主診醫生作出跟進及檢
察，以確保您的安全。 
是項研究涉及的風險相當低。在帶氧運動和肌肉耐力訓練過程中，
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閣下有可能會感覺肌肉酸軟和疲勞，只要閣下有適當的熱身和冷卻運
動，並有固定休息，就能減輕這種感覺。另外，在六分鐘步行測試中，
閣下亦有可能感到體力透支，所以研究員會站在閣下身邊以策安全並不
斷監察閣下的辛苦感覺，心跳和血壓。如果閣下在參與時受傷，我們將
會盡力提供協助及建議，而東華醫院心臟康復中心主診醫生亦會提供專
業的治療。 
所有參加者個人資料將會絕對保密，一切資料只作研究用途。參與
時，閣下將會給予一個數字編號，以作記錄時、結果分析及報告時之用，
閣下的名字將不會向外發表，只有與研究有關的人等才可進入資料庫。 
是項研究希望有助我們了解步行器的斜度對冠心病康復者的運動
機能之影響, 對於日後在運動治療方面, 提供更有效的處來提高訓練的
效果。研究獲得的資料，並能幫助物理治療師對冠心病康復者的運動設
計作出貢獻。 
參與是項研究純屬個人自願，閣下有權自行決定參加與否。若閣下
決定參加是項研究, 則需簽署一份同意書。此資料表及同意書將給予參
加者作保留。閣下仍亦可在同意後隨時退出是項研究，而不需要負上任
何責任，亦不會影響閣下所接受的治療質素。 
歡迎閣下隨時就有關於本研究作出查詢，研究員梁舜欣小姐是很樂
意為閣下解答的。查詢可致電 25898293。 多謝閣下參與是項研究。 
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參加研究同意書 
檔案編號: 
參加者編號: 
 
研究題目: “ 第二階段冠心病康復運動訓練：比較步行器的水平步行訓練
及斜度步行訓練，對冠心病康復者在運動機能之影響”  
 
督導員: Dr Stephen Fallows, Research Co-ordinator of Centre for Exercise & Nutrition 
Science in University College Chester. 
 
研究員: 梁舜欣小姐 
東華醫院二級物理治療師 
 
我， ____________________ (被研究者姓名)，在此同意作為受試者參加以上專題
研究， 
 
1. 我確定我於___/___/___已細閱及明白是項研究的資料表，給予機會詢問有
關該測試的問題到該測試的步驟，並已獲得滿意的回答。 
2. 我已知道我的參與屬自願性質，並可以隨時終止測試而無需給予任何理
由，或由此而影響本人之醫療或法定權利。 
3. 我已知道這個測試的結果可被發表，但有關我個人的資料將獲得保密。 
4. 我已知道這個測試的結果和醫療記錄可以被 University College Chester 和
東華醫院的有關人仕參閱。我並批准這些人仕獲得我的記錄。 
 
受試者姓名 __________________   簽署 _______________________ 
 
作證人姓名 __________________   簽署 _______________________ 
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日期 ________________________    
副本： 
參加者 
研究員 
醫院紀錄 
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Appendix J 
Data Collection Sheet 
Data Collection sheet 
Compare the functional exercise capacity outcome of 
Horizontal-Treadmill with Graded-Treadmill walking training in 
Cardiac Rehabilitation Program by using Six-Minute Walk Test 
 
 
 
 
 
 
 
Group: GT / HT 
 
 
Patient No:_____ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remark:_______________________________________________________________
______________________________________________________________________ 
PCI intervention date   
Phase II 
Starting date  
Finished date  
Total sessions completed  
Gender  
Height (m)  
 
 Pre Phase II CRP 
Post Phase II 
CRP 
Weight (kg)   
BMI   
BF (%)   
WHR   
6MWT (m)   
Heart Rate in 6MWT (bpm) Resting Max 
Resting 
Max 
Aerobic Capacity (METs) 
Treadmill Protocol:______ 
 
 
 
 1st session The last session 
Speed at Treadmill 
mph   
Kmh-1   
 
Gum Label 
